Long-Term Outcomes of HIV-Infected Patients with <95% Rates of Adherence to Nonnucleoside Reverse-Transcriptase Inhibitors

被引：16
作者：
Apisarnthanarak, Anucha [2 ]
Mundy, Linda M. [1 ]
机构：
[1] LM Mundy LLC, Bryn Mawr, PA USA
[2] Thammasat Univ Hosp, Div Infect Dis, Pathum Thani 12120, Thailand
来源：
CLINICAL INFECTIOUS DISEASES | 2010年 / 51卷 / 01期
关键词：
THERAPY; EFAVIRENZ;
D O I：
10.1086/653445
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：115 / 117
页数：5
相关论文
共 7 条
[1]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[2]   Current and future management of treatment failure in low- and middle-income countries [J].
Boyd, Mark A. .
CURRENT OPINION IN HIV AND AIDS, 2010, 5 (01) :83-89
[3]  
Haas DW, 2004, AIDS, V18, P2391
[4]   Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors [J].
Maggiolo, F ;
Ravasio, L ;
Ripamonti, D ;
Gregis, G ;
Quinzan, G ;
Arici, C ;
Airoldi, M ;
Suter, F .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (01) :158-163
[5]   Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [J].
Paterson, DL ;
Swindells, S ;
Mohr, J ;
Brester, M ;
Vergis, EN ;
Squier, C ;
Wagener, MM ;
Singh, N .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) :21-30
[6]   Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection [J].
Robbins, GK ;
De Gruttola, V ;
Shafer, RW ;
Smeaton, LM ;
Snyder, SW ;
Pettinelli, C ;
Dube, MP ;
Fischl, MA ;
Pollard, RB ;
Delapenha, R ;
Gedeon, L ;
van der Horst, C ;
Murphy, RL ;
Becker, MI ;
D'Aquila, RT ;
Vella, S ;
Merigan, TC ;
Hirsch, MS ;
Nokta, M ;
Johnson, V ;
Morse, G ;
Putnam, B ;
Klebert, M ;
Martinez, A ;
Chiesi, A ;
Tomino, C ;
Deeks, S ;
Testa, M ;
Nevin, T ;
Levin, J ;
French, V ;
Fennell, O ;
Stevens, M ;
Grosso, R ;
Dusak, B ;
Hodder, S ;
Squibb, M ;
Brothers, C ;
Tolson, J ;
Leavitt, R ;
Manion, D ;
Ruiz, N ;
Morrisey, K ;
Quart, B ;
Jennings, C ;
Dascomb, S ;
Cooper, M ;
Murphy, M ;
Blakelock, K ;
Doolan, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24) :2293-2303
[7]   Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults [J].
Staszewski, S ;
Morales-Ramirez, J ;
Tashima, KT ;
Rachlis, A ;
Skiest, D ;
Stanford, J ;
Stryker, R ;
Johnson, P ;
Labriola, DF ;
Farina, D ;
Manion, DJ ;
Ruiz, NM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1865-1873
1